While brand-name pomalidomide is produced by big pharmaceutical companies like Celgene (Bristol-Myers Squibb), the emergence of generic manufacturers has played a crucial role in making this drug more accessible. Generics are equivalent versions of the original drug but are sold at lower prices once the patent on the brand-name drug expires. Generic pomalidomide manufacturers make it possible for more patients, especially those in low-income countries, to receive life-saving treatment. These manufacturers follow strict regulatory guidelines to ensure that their generic versions are as safe and effective as the original branded drugs.